Progesterone for maintenance tocolytic therapy after threatened preterm labour: A randomised controlled trial

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 48, Issue 1, 2008, Pages 58-63

  Borna, Sedigheh ^a   Sahabi, Noshin ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Latency period; Preterm labour; Progesterone; Recurrence of preterm labour

Indexed keywords

AMPICILLIN; BETAMETHASONE; MAGNESIUM SULFATE; PROGESTERONE;

ADULT; ANXIETY; ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONGENITAL MALFORMATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; HEADACHE; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; IRRITABILITY; LOW BIRTH WEIGHT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MOOD CHANGE; NECROTIZING COLITIS; NEWBORN SEPSIS; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESPIRATORY DISTRESS SYNDROME; SIDE EFFECT; TOCOLYSIS;

ADULT; FEMALE; HUMANS; MAGNESIUM SULFATE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PROGESTERONE; PROGESTINS; SUPPOSITORIES; TOCOLYSIS; TOCOLYTIC AGENTS;

EID: 39049112941     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2007.00803.x     Document Type: Article

References (21)

1. Berkowitz GS, Papiernik E. Epidemiology of preterm births. Epidemiol Rev 1993 15 : 414 443.
2. Dodd JM, Crowther CA, Dare MR, Middleton P. Oral betamimetics for maintenance therapy after threatened preterm labor. Cochrane Database Syst Rev 2006 1 CD003927.
3. Sanchez-Ramos L, Kaunitz AM, Gaudier FL, Delke I. The efficacy of maintenance therapy after acute tocolysis: Meta-analysis. Am J Obstet Gynecol 1999 181 : 484 490.
4. Thornton JG. Maintenance tocolysis. BJOG 2005 112 (Suppl. 1 118 121.
5. Daya S, Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst Rev 2004 1 CD004830.
6. Oates-Whitehead RM, Haas DM, Carrier JA. Progestogen for preventing miscarriage. Cochrane Database Syst Rev 2003 4 CD003511.
7. Friedler S, Raziel A, Schachter M, Strassburger D, Bukovsky I, Ron-El R. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: A comparative study between vaginal and oral administration. Hum Reprod 1999 14 : 1944 1948.
8. Dudas I, Gidai J, Czeizel AE. Population-based case-control teratogenic study of hydroxyprogesterone treatment during pregnancy. Congenit Anom (Kyoto) 2006 46 : 194 198.
9. El-Zibdeh MY. Dydrogesterone in the reduction of recurrent spontaneous abortion. J Steroid Biochem Mol Biol 2005 97 : 431 434. Epub 2005 Oct 25.
10. Yemini R, Borenstein M, Dreazen E et al. Prevention of premature labor by 17-α-hydroxyprogesterone caproate. Am J Obstet Gynecol 1975 151 : 574 577.
11. Dodd JM, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth. Cochrane Database Syst Rev 2006 1 CD004947.
12. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003 188 : 419 424.
13. Meis PJ, Klebanoff M, Thom E et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003 348 : 2379 2385.
14. Eduardo B, Fonseca MD, Ebru Celik MD et al. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007 357 : 462 469.
15. Rouse DJ, Caritis SN, Peaceman AM, Sciscione A. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007 357 : 454 461.
16. Noblot G, Audra P, Dargent D et al. The use of micronized progesterone in the treatment of menace of preterm delivery. Euro J Obstet Gynecol Reprod Biol 1991 40 : 203 209.
17. Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A. Cervical length changes during preterm cervical ripening: Effects of 17α- hydroxyprogesterone caproate. Am J Obstet Gynecol 2007 196 : 421 427.
18. Siiteri PK, Serón-Ferré M. Some new thoughts on the feto-placental unit and parturition in primates. In : Novy MJ, Resko JA, eds. Fetal Endocrinology. New York : Academic Press, 1981 1 34.
19. Garfield RE, Kannan MS, Daniel EE. Gap junction formation in myometrium: Control by estrogens, progesterone, and prostaglandins. Am J Physiol 1980 238 : C81 C89.
20. Challis JRG. Sharp increases in free circulating oestrogens immediately before parturition in sheep. Nature 1971 229 : 208 208.
21. Mitchell B, Cruickshank B, McLean D, Challis J. Local modulation of progesterone production in human fetal membranes. J Clin Endocrinol Metab 1982 55 : 1237 1239.